Biography
Danielle brings a decade-plus of leadership in rare disease therapeutics, having managed cross-functional teams in both biotechnology startups and major pharmaceutical firms. She is highly regarded for her expertise in the strategic development of AI-enabled diagnostic tools, accelerating the identification and treatment of rare conditions. Her portfolio includes overseeing clinical research, business development, and patient engagement, with a strongcommitment to improving health outcomes among underserved populations. Danielle holds advanced degrees in both science and business administration.